Impact of CYP3A5 and MDR1 polymorphisms on tacrolimus and sirolimus kinetics of kidney transplant recipients

被引：0
|
作者：
Frisman, M
Renders, L
Haenisch, S
Mosyagin, I
Cascorbi, I
机构：
[1] Univ Hosp Schleswig Holstein, Inst Pharmacol, D-24105 Kiel, Germany
[2] Univ Hosp Schleswig Holstein, Dept Nephrol, D-24105 Kiel, Germany
来源：
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 2005年 / 61卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：705 / 706
页数：2
相关论文
共 50 条
  • [1] IMPACT OF CYP3A5, CYP3A4 AND MDR1 GENE POLYMORPHISMS ON TROUGH CONCENTRATIONS OF TACROLIMUS, CYCLOSPORINE AND SIROLIMUS IN RENAL TRANSPLANT RECIPIENTS
    Shi, Yunying
    Li, Yi
    Cai, Bei
    Cai, Bei
    Zou, Yuangao
    Tao, Ye
    Wang, Lanlan
    [J]. TRANSPLANT INTERNATIONAL, 2013, 26 : 84 - 84
  • [2] CYP3A5 and MDR1 polymorphisms in pediatric kidney transplant recipients receiving calcineurin inhibitors
    Tirelli, Amedea Silvia
    Ghio, Luciana
    Ferraresso, Mariano
    Belingheri, Mirco
    Berardinelli, Luisa
    Turolo, Stefano
    Torresani, Erminio
    Edefonti, Alberto
    [J]. THERAPEUTIC DRUG MONITORING, 2007, 29 (04) : 544 - 544
  • [3] Influence of CYP3A5 and MDR1 (ABCB1) polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients
    Tsuchiya, N
    Satoh, S
    Tada, H
    Li, ZH
    Ohyama, C
    Sato, K
    Suzuki, T
    Habuchi, T
    Kato, T
    [J]. TRANSPLANTATION, 2004, 78 (08) : 1182 - 1187
  • [4] IMPACT OF MDR1 AND CYP3A5 GENETIC POLYMORPHISMS ON TACROLIMUS DOSAGE REQUERIMENTS AND ACUTE REJECTION IN CAUCASIAN LIVER TRANSPLANT RECIPIENTS
    Mo Alamo, Jose
    Gomez-Bravo, Miguel A.
    Brunet, Merce
    Salcedo, Magdalena
    Fondevilla, Constantino
    Suarez, Francisco
    Castellote, Jose
    Rufian, Sebastian
    Pons, Jose A.
    Bilbao, Itxarone
    Torrademe, Elisabet
    Barrera, Lydia
    [J]. TRANSPLANT INTERNATIONAL, 2011, 24 : 247 - 247
  • [5] Impact of MDR1 and CYP3A5 Genetic Polymorphisms on Tacrolimus Dosage Requirements and Acute Rejection in Caucasian Liver Transplant Recipients
    Serra, M. Brunet
    Bravo, M. A. Gomez
    Salcedo, M.
    Suarez, F.
    Castellote, J.
    Rufian, S.
    Pons, J. A.
    Bilbao, I.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 186 - 186
  • [6] Influence of CYP3A5 and MDR1(ABCB1) Polymorphisms on the Pharmacokinetics of Tacrolimus in Chinese Renal Transplant Recipients
    Rong, G.
    Jing, L.
    Deng-Qing, L.
    Hong-Shan, Z.
    Shai-Hong, Z.
    Xin-Min, N.
    [J]. TRANSPLANTATION PROCEEDINGS, 2010, 42 (09) : 3455 - 3458
  • [7] Impact of MDR1 and CYP3A5 Genetic Polymorphisms on Tacrolimus Dosage Requirements and Acute Rejection in Caucasian Liver Transplant Recipients.
    Brunet Serra, Merce
    Gomez Bravo, Miguel Angel
    Salcedo, Magdalena
    Fondevilla, Constantino
    Suarez, Francisco
    Castellote, Jose
    Rufian, Sebastian
    Pons, Jose A.
    Bilbao, Itxarone
    [J]. LIVER TRANSPLANTATION, 2011, 17 (06) : S150 - S150
  • [8] Genetic Polymorphisms in CYP3A5 and MDR1 Genes and Their Correlations With Plasma Levels of Tacrolimus and Cyclosporine in Renal Transplant Recipients
    Mendes, J.
    Martinho, A.
    Simoes, O.
    Mota, A.
    Breitenfeld, L.
    Pais, L.
    [J]. TRANSPLANTATION PROCEEDINGS, 2009, 41 (03) : 840 - 842
  • [9] Effect of CYP3A5 and MDR1 gene polymorphism on pharmacokinetics of tacrolimus in renal transplant recipients
    Tsuchiya, N
    Satoh, S
    Tada, H
    Li, ZH
    Ohyama, C
    Sato, K
    Suzuki, T
    Kato, T
    Habuchi, T
    [J]. JOURNAL OF UROLOGY, 2004, 171 (04): : 490 - 491
  • [10] Impact of CYP3A5 and MDR1(ABCB1) C3435T polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients
    Tada, H
    Tsuchiya, N
    Satoh, S
    Kagaya, H
    Li, Z
    Sato, K
    Miura, M
    Suzuki, T
    Kato, T
    Habuchi, T
    [J]. TRANSPLANTATION PROCEEDINGS, 2005, 37 (04) : 1730 - 1732
12345